End-tidal CO2 levels lower in subclinical and overt hypothyroidism than healthy controls; no relationship to thyroid function tests by Ansarin, Khalil et al.
© 2011 Ansarin et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of General Medicine 2011:4 29–33
International Journal of General Medicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
29
OrIGInAL reseArch
open access to scientific and medical research
Open Access Full Text Article
DOI: 10.2147/IJGM.S16252
end-tidal cO2 levels lower in subclinical  
and overt hypothyroidism than healthy controls; 
no relationship to thyroid function tests
Khalil Ansarin1 
Babak niroomand1 
Farzad najafipour2 
naser 
Aghamohammadzadeh2 
Mitra niafar2 
Akbar sharifi1 
Mohammadali M shoja1
1Tuberculosis and Lung Disease 
research center, 2Department  
of endocrinology, Tabriz University  
of Medical sciences, Tabriz, Iran
correspondence: Khalil Ansarin 
Tuberculosis and Lung Disease research 
center, Tabriz University  
of Medical sciences, Tabriz, Iran 
Tel +98 9144134368 
Fax +98 4113378093 
email kansarin@yahoo.com
Background: Hypoventilation is a frequently suspected complication of hypothyroidism.
Objective: In this study we examined the hypothesis that changes in alveolar v  entilation, as 
  measured by end-tidal carbon dioxide (Et-CO2), differ between patients with mild (  subclinical) 
and overt (clinical) thyroid hormone deficiency, and both differ from healthy control subjects.
Methods: A total of 95 subjects, including 33 with subclinical hypothyroidism (an elevated 
thyroid-stimulating hormone (TSH) level and a normal thyroxin (fT4) level), 31 with overt 
hypothyroidism (elevated TSH and decreased fT4), and 31 healthy controls. All subjects were 
female and were evaluated clinically by an endocrinologist for evidence of thyroid disease and 
categorized on the basis of thyroid hormone levels. Et-CO2 was measured using a capnograph. 
Et-CO2 levels were measured three times and the mean value was considered as the mean level 
for the individual.
Results: Mean Et-CO2 values of the subclinical hypothyroidism group were significantly 
lower than those of the healthy controls (31.79 ± 2.75 vs 33.81 ± 2.38; P = 0.01). Moreover, 
mean Et-CO2 values for the overt hypothyroidism group were significantly lower than those for 
healthy controls (32.13 ± 3.07 vs 33.81 ± 2.38; P = 0.04). There was a significant correlation 
between Et-CO2 values and TSH levels (r = -0.24; P = 0.01). However, Et-CO2 values were not 
correlated with fT4 levels (r = 0.13; P = 0.20).
Conclusions: Alveolar ventilation, as inferred from lower Et-CO2 levels, is higher in subjects 
with subclinical hypothyroidism and overt hypothyroidism (lower Et-CO2) than in healthy con-
trols. Furthermore, Et-CO2 levels have no relationship to the levels of TSH or fT4. The lower 
Et-CO2 in these patients with hypothyroidism, particularly at the subclinical stage, suggests 
presence of hyperventilation, which may be related to direct effect of TRH on respiratory center 
or to local changes within the lung.
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Introduction
Hypothyroidism is a relatively common problem worldwide often with insidious onset 
and is relatively asymptomatic. It is divided in two stages: mild stage (subclinical), or 
symptomatic (overt). A community survey carried out in the United States identified 
hypothyroidism in 4.6% of the US population: 0.3% had overt hypothyroidism and 
4.3% had what was described as subclinical or mild hypothyroidism.1 Subclinical 
h  ypothyroidism can progress to overt hypothyroidism, particularly in thyroid peroxidase 
(TPO)-positive patients in whom the annual risk of developing overt hypothyroidism 
can approach 4%.2 There can be clinical manifestations in mild hypothyroid patients 
requiring hormone replacement therapy.3 Hypothyroidism can affect all organ systems, 
and its manifestations are largely a function of the degree of hormone deficiency.3International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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There has been interest in the cardiorespiratory 
  consequences of hypothyroidism as coronary heart dis-
ease, congestive heart failure, hypertension, pericardial 
  effusion, and rhythm disturbances have been documented 
as c  omplications of the hypothyroid state.4–9 Furthermore, 
there is growing evidence regarding an association between 
subclinical hypothyroidism and atherosclerosis, coronary 
heart diseases, and hypertension.4,7,8,10 Subclinical and overt 
hypothyroidism can lead to a variety of respiratory changes. 
First, observational studies and case reports have associated 
hypothyroidism with obstructive sleep apnea (OSA).11,12 
These studies report conflicting data: a high association 
between OSA and hypothyroidism has been reported in some 
studies, while no association has been documented in others. 
Second, abnormalities in pulmonary function tests including 
a decrease in the diffusing capacity for carbon monoxide 
and an increased incidence of pleural effusions in patients 
with overt hypothyroidism have been reported.13–15   Alveolar 
hypoventilation is a particularly important issue among 
respiratory complications of hypothyroidism. Myxedema 
and hypothyroid states can cause depression of the hypoxic 
ventilatory drive which is responsive to hormone replace-
ment therapy.16 In the extreme case of myxedema, respiratory 
depression can lead to alveolar hypoventilation and pro-
gressive hypoxemia, and ultimately to marked hypercapnia 
and coma.17 In addition, mild respiratory muscle weakness 
proportional to the degree of thyroid dysfunction is a common 
finding in primary and iatrogenic hypothyroid states of short 
duration. This weakness, which affects both inspiratory and 
expiratory muscles, is reversible with treatment.18
The current study utilized a simple and noninvasive 
method to evaluate alveolar ventilation in ambulatory 
h  ypothyroid patients (both clinical and subclinical), 
  focusing p  articularly on ventilation in patients suffering 
from s  ubclinical hypothyroidism. The study examined the 
hypothesis that changes in ventilation differ significantly 
between patients with mild (subclinical) and overt (clinical) 
thyroid hormone deficiency, and that these two groups differ 
from healthy controls.
Materials and methods
Sixty-four ambulatory adult females aged 18–65 years 
referred to a university-affiliated endocrinology clinic 
with clinical suspicion of thyroid disease were selected 
and enrolled in this study. The study was approved by the 
local ethics committee and written informed consent was 
obtained from each subject. For selection, subjects under-
went a c  omprehensive history and physical e  xamination, 
and m  edical, drug, and habitual history were taken into 
c  onsideration. In particular, history of oral contracep-
tives, salicylates, methylxanthines, and β-adrenergic 
  administration; presence of any cardiorespiratory, renal, or 
endocrinologic diseases potentially affecting respiration; and 
habits such as smoking of any kind and duration, drug use, 
or opiate consumption were considered as exclusion criteria. 
All subjects were clinically evaluated by an endocrinologist 
for evidence of thyroid disease and categorized on the basis 
of thyroid hormone levels. Physical examination revealed 
goiter in some patients; however these were not large enough 
to affect the respiratory system. Body mass index (BMI) was 
calculated for all subjects. Thyroid-stimulating hormone 
(thyrotropin, TSH) and free thyroxine (fT4) were measured 
in all subjects using a radioimmunometric assay. Subclini-
cal hypothyroidism was defined as normal serum fT4 with 
slightly elevated serum TSH levels. Overt hypothyroidism 
was diagnosed in those with decreased fT4 and elevated TSH 
levels. The normal ranges for TSH and fT4 were considered 
to be 0.3–4.2 µU/mL and 0.8–1.7 ng/dL, respectively.
End-tidal carbon dioxide (Et-CO2) was measured in 
all subjects using a capnograph (Microstream®; Oridion, 
  Needham, MA), which is a portable monitor that measures 
and displays Et-CO2 values and respiratory rates. It has a 
nasal prong and an oral cannula extending downward. In this 
study, after inserting the nasal prong into the nostrils, a nor-
mal capnographic waveform was recorded after 2–5 minutes. 
To achieve a power of 80% with a type I error rate of 0.05, 
the sample size was calculated as 31 patients for each group. 
The mean value of three independent measurements was 
considered to be the Et-CO2 value of the individual. Data 
were presented as mean ± standard deviation or median (inter-
quartile range). Statistical analysis was performed with SPSS 
software (version 16.0 for Windows; SPSS Inc., Chicago, 
IL), analysis of variance (ANOVA), and Student’s t-test. A 
Spearman correlation test was used to identify correlations 
between values in the experimental groups. A P value less 
than 0.05 was considered statistically significant.
Results
Ninety-five individuals were included in the study: 33 with 
subclinical hypothyroidism, 31 with overt hypothyroidism, and 
31 healthy controls. The mean ages and BMI measurements 
for each of the groups were comparable and are summarized in 
Table 1. Mean values for TSH, fT4, and Et-CO2 for each of the 
three groups are presented in Table 2. Mean Et-CO2 values for 
the subclinical hypothyroidism group was significantly lower 
than those for healthy controls (31.79 ± 2.75 vs 33.81 ± 2.38; International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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P = 0.012). Moreover, mean Et-CO2 values for the overt 
hypothyroidism group were significantly lower than those for 
healthy controls (32.13 ± 3.07 vs 33.81 ± 2.38; P = 0.048). 
Nonetheless, mean Et-CO2 values for overt and subclinical 
hypothyroidism groups were comparable (P . 0.05).
Analysis of data for relationship between Et-CO2 values 
and TSH levels revealed a significant correlation (r = -0.24; 
P = 0.01). However, Et-CO2 values were not correlated 
with fT4 levels (r = 0.13; P = 0.20). There was a statistically 
significant positive correlation between Et-CO2 values and 
BMI measurements (r = 0.288; P = 0.005). However, there 
was no significant correlation between Et-CO2 values and 
respiratory rate or age of the subjects (P . 0.05).
Discussion
Most studies on the relationship between hypothyroidism 
and alveolar ventilation emphasize the depression of respira-
tory system in hypothyroidism. Zwillich et al demonstrated 
that myxedema and the hypothyroidism state after thyroid 
ablation depressed the hypoxic ventilatory drive, and that 
this depression was responsive to thyroid hormone replace-
ment therapy.16 In addition, depression of the   hypercapnic 
ve  ntilatory drive was reported in myxedema but this 
r  elationship was not significant in individuals suffering from 
milder h  ypothyroidism, and there was no improvement after 
h  ormone replacement therapy.
In the present study, a simple and noninvasive method 
was used to evaluate the alveolar ventilation in patients with 
thyroid hormone deficiency. Alveolar ventilation, the main 
determinant of arterial and Et-CO2 levels, is defined as the 
portion of minute ventilation that reaches the alveoli and 
participates in gas exchange. In our study, minute ventilation 
inferred from Et-CO2 was significantly higher in subjects 
suffering from subclinical hypothyroidism than those with 
overt hypothyroidism or healthy controls. This would suggest 
that patients with thyroid hormone deficiency, particularly 
mild (subclinical) or moderate, hyperventilate relatively more 
often compared to normal individuals.
A year-long study by Pandya et al documented four 
cases of severe hypothyroidism with long-term dependency 
on v  entilators; thyroid hormone replacement therapy was 
  successful in weaning three of the subjects off the ventilation.19 
Similarly, several retrospective studies have confirmed ventila-
tory dependency in hypothyroidism patients.20 There have been 
reports related to CO2 retention in myxedema coma.13
It has been reported that hypothyroidism can cause 
weakness of inspiratory and expiratory muscles, and that 
respiratory pump failure could be secondary to muscle 
weakness in severe hypothyroidism.18 Furthermore, a study 
by Baldwin et al demonstrated that thyroid deficiency in rats 
limited the endurance capacity of skeletal muscles.21
Diaphragmatic dysfunction ranging from mild   weakness 
to severe forms of diaphragmatic paralysis and phrenic 
nerve neuropathy are proposed as mechanisms of respira-
tory f  ailure in patients with thyroid hormone deficiency.22,23 
In the present study, the patients with mild/moderate 
  hypothyroidism presented with higher minute ventilation, 
rather than lower, compared to the healthy controls. This 
paradoxical result may be related to direct stimulatory 
effect of TRH on ventilation while no muscular weakness 
has settled in yet. Another explanation for this apparently 
discrepant finding would be the effect of secondary changes 
in the lung with lung juxtacapillary receptor stimulation 
that in turn increases ventilation with lowering arterial 
and Et-CO2 values. T  herefore, it seems that even though 
severe hypothyroidism is an etiological factor in alveolar 
h  ypoventilation, it is unclear what relationship, if any, exists 
between subclinical and mild symptomatic hypothyroidism 
and the pulmonary ventilation system.
The respiratory system is controlled by the autonomic 
n  ervous system but hormones also play a role. In a com-
prehensive article regarding breathing and hormones, 
Saaresranta demonstrated that a number of hormones, 
including   thyrotropin-releasing hormone (TRH), are involved 
Table 2 et-cO2 values, respiratory rates, and thyroid function 
values in the three groups
Control  
(n = 31)
Subclinical  
hypothyroidism 
(n = 33)
Overt  
hypothyroidism 
(n = 31)
et-cO2 33.81 ± 2.38 31.79 ± 2.75a 32.13 ± 3.07b
Tsh (µU/mL) 1.1 (0.9–2.4) 8.2 (6.85–11.3) 44 (30–92)
fT4 (ng/dL) 1.17 ± 0.22 1.05 ± 0.20 0.42 ± 0.19
respiratory  
ratec
17.81 ± 2.72 17.85 ± 2.65 18.29 ± 2.51
Notes:  aP = 0.012 between subclinical hypothyroidism and controls;  bP = 0.048 
between overt hypothyroidism and controls;  cNo significant difference between 
three groups (P . 0.05).
Abbreviations: et-cO2, end-tidal carbon dioxide; fT4, free thyroxine; Tsh, thyroid 
stimulating hormone.
Table 1 Age and BMI of the patients in three studied groups 
(P . 0.05)
Control 
(n = 31)
Subclinical  
hypothyroidism 
(n = 33)
Overt  
hypothyroidism 
(n = 31)
Age (year)   30.3 ± 4.9   35.3 ± 11.7   33.3 ± 12.41
BMI (kg/m2) 25.22 ± 4.46 25.40 ± 5.39 26.14 ± 5.73
Abbreviation: BMI, body mass index.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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in c  ontrolling the breathing.24 There is a growing body of 
  evidence that there is an association between TRH and the 
respiratory system. Injecting TRH into an important compo-
nent of the rostral ventrolateral medulla, the retrotrapezoid 
nucleus, of anesthetized rats had powerful stimulatory 
effects on the product of integrated phrenic amplitude and 
frequency, and this response was dose-dependent.25 There 
was an increase in ventilation, O2 consumption, and body 
temperature after TRH injection into the retrotrapezoid 
nucleus in conscious rats, and it was concluded that TRH 
could have an important role as a state-dependent   modulator 
of   breathing control.26 It has also been demonstrated that 
intracerebroventricular application of TRH induces a 
dose-dependent and sustained increase in the ventilation 
rate, relative tidal volume, and relative respiratory minute 
v  olume.27 A study carried out on anesthetized, vagotomized, 
paralyzed, and artificially ventilated rabbits concluded that 
microinjection of TRH into different regions of the medullary 
respiratory center exerted a depressant effect on respiration 
at medullary levels by   acting on rostral expiratory neurons, 
but emphasized that TRH could have stimulatory effects if 
injected into other regions of the respiratory center.28 Despite 
numerous studies, the exact physiological effect of TRH on 
the respiratory system and its participation in the adjustment 
of breathing during disease has not been elucidated.
In the present study, mean Et-CO2 values were lower in 
subclinical hypothyroid patients than in the control group. 
In addition, there was no correlation between mean TSH and 
fT4 levels, and Et-CO2 values. The ultimate test to assess 
adequate ventilation is the invasive determination of partial 
pressure of CO2 in arterial blood, but capnography, utilized 
in this study, provides information concerning ventilation, 
perfusion, and metabolism.29 However, some studies have 
demonstrated a correlation between Et-CO2 and arterial CO2 
levels.30,31
Several pathophysiological mechanisms, ranging from 
neuromuscular and pulmonary factors such as diaphragmatic 
and respiratory muscle weakness, to central factors such as 
decreased ventilatory drive, can be considered as causes 
of respiratory failure and resulting hypercapnia. In severe 
hypothyroidism, myxedematous involvement of respiratory 
muscles and depression of both the hypoxic and hypercapnic 
ventilatory drive can cause alveolar hypoventilation and CO2 
retention, which in turn can contribute to the development of 
myxedema.3 However, in mild symptomatic or subclinical 
hypothyroidism, interactions between hormonal changes 
such as increased TRH and/or TSH and neuromuscular and 
pulmonary changes affecting respiratory function could be 
important. Such interactions could account for the variations 
in minute ventilation in this study.
There were important limitations to the current research. 
Measurements of TSH and fT4 are sufficient for diagnosis 
and the categorization of hypothyroid patients, but measur-
ing serum levels of fT4 would have been of use in defining 
relationships between variables. Another limiting factor in 
this study was the small sample size.
Conclusions
Unlike patients suffering from severe hypothyroidism and 
myxedema, asymptomatic or mild symptomatic hypothyroid 
patients are often regarded as ‘stable’ in terms of clinical sta-
tus. Interactions between several factors affect the respiratory 
system including neurohumoral, neuromuscular, and pulmo-
nary factors. Hypothyroidism, particularly at the   subclinical 
stage, results in hyperventilation as d  emonstrated by a low 
Et-CO2. It is possible that such patients demonstrate increased 
alveolar ventilation in relation to CO2 production.
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